neuroAD is technology-based treatment option that requires time and commitment. The therapy has improved the quality of life for many people suffering from mild to moderate Alzheimer’s Disease symptoms. To see if neuroAD is appropriate for you, talk to your doctor or contact a clinic.
neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.